{"log_id": 3574206592618552812, "direction": 0, "words_result_num": 44, "words_result": [{"probability": {"variance": 0.000353, "average": 0.99502, "min": 0.87246}, "location": {"width": 857, "top": 211, "height": 59, "left": 149}, "words": "酒石酸布托啡诺上市前国外临床试验共入组了2446名患者。其中约有一半患者使用酒石酸布托啡诺"}, {"probability": {"variance": 1.7e-05, "average": 0.997803, "min": 0.97637}, "location": {"width": 899, "top": 243, "height": 58, "left": 107}, "words": "注射液,其余患者使用酒石酸布托啡诺鼻喷剂。各给药途径下布托啡诺的不良反应发生率和类型均与阿片"}, {"probability": {"variance": 3.6e-05, "average": 0.996738, "min": 0.982095}, "location": {"width": 144, "top": 275, "height": 33, "left": 107}, "words": "类镇痛药物相似"}, {"probability": {"variance": 0.00037, "average": 0.993449, "min": 0.894715}, "location": {"width": 860, "top": 308, "height": 61, "left": 145}, "words": "以下列出了患者长期和短期所有给药途径给予布托啡诺后的不良反应数据。未进行安慰剂作用的校正"}, {"probability": {"variance": 0.001478, "average": 0.987085, "min": 0.840446}, "location": {"width": 313, "top": 343, "height": 36, "left": 113}, "words": "或减去对照试验中安慰剂组的发生率"}, {"probability": {"variance": 0.003543, "average": 0.974416, "min": 0.651853}, "location": {"width": 691, "top": 376, "height": 52, "left": 142}, "words": "临床试验中最为常见的不良反应为嗜睡(43%)、眩晕(19%)、恶心和或呕吐(13%)"}, {"probability": {"variance": 2e-06, "average": 0.998977, "min": 0.990842}, "location": {"width": 741, "top": 408, "height": 55, "left": 143}, "words": "以下的不良反应在临床试验中的发生率在1%或以上,考虑可能与酒石酸布托啡诺有关"}, {"probability": {"variance": 0.004888, "average": 0.976959, "min": 0.726615}, "location": {"width": 265, "top": 444, "height": 33, "left": 142}, "words": "全身:无力/嗜睡、头痛、热感"}, {"probability": {"variance": 0.000138, "average": 0.99516, "min": 0.955378}, "location": {"width": 261, "top": 476, "height": 34, "left": 139}, "words": "心血管系统:血管舒张、心悸"}, {"probability": {"variance": 0.021562, "average": 0.952596, "min": 0.446623}, "location": {"width": 445, "top": 508, "height": 42, "left": 137}, "words": "消化系统:厌食、便秘、口干、恶心或m呕吐、胃痛"}, {"probability": {"variance": 4e-05, "average": 0.997599, "min": 0.960751}, "location": {"width": 828, "top": 539, "height": 58, "left": 137}, "words": "神经系统:焦虑、精神错乱、头晕、欣快感、漂浮感、失眠、神经过敏、感觉异常、嗜睡、震颤"}, {"probability": {"variance": 0.000214, "average": 0.996582, "min": 0.903545}, "location": {"width": 846, "top": 571, "height": 59, "left": 135}, "words": "呼吸系统:支气管炎、咳嗽、呼吸困难、鼻衄、鼻充血、鼻刺激、咽炎、鼻炎、鼻窦出血、鼻窦炎"}, {"probability": {"variance": 1.8e-05, "average": 0.996207, "min": 0.987169}, "location": {"width": 119, "top": 604, "height": 27, "left": 97}, "words": "上呼吸道感染"}, {"probability": {"variance": 0.000193, "average": 0.995222, "min": 0.943932}, "location": {"width": 306, "top": 636, "height": 36, "left": 134}, "words": "皮肤及附属器官:出汗湿冷、瘙痒"}, {"probability": {"variance": 0.000207, "average": 0.993453, "min": 0.951131}, "location": {"width": 400, "top": 668, "height": 39, "left": 131}, "words": "特殊感觉:视力模糊、耳痛、耳鸣、味觉异常"}, {"probability": {"variance": 0.000788, "average": 0.990391, "min": 0.879494}, "location": {"width": 705, "top": 700, "height": 50, "left": 132}, "words": "以下的不良反应在临床试验中的发生率少于1%:考虑可能与酒石酸布托啡诺有关"}, {"probability": {"variance": 0.002694, "average": 0.965771, "min": 0.822817}, "location": {"width": 203, "top": 731, "height": 32, "left": 130}, "words": "心血管:低血压、晕厥"}, {"probability": {"variance": 0.005901, "average": 0.973632, "min": 0.640991}, "location": {"width": 514, "top": 763, "height": 43, "left": 130}, "words": "神经系统:异梦、激动、焦虑、幻觉、敌意、药物戒断症状"}, {"probability": {"variance": 0, "average": 0.952285, "min": 0.952285}, "location": {"width": 131, "top": 746, "height": 53, "left": 865}, "words": "药"}, {"probability": {"variance": 0.004585, "average": 0.97957, "min": 0.735675}, "location": {"width": 263, "top": 796, "height": 32, "left": 129}, "words": "皮肤及附属器官:皮疹/荨麻疹"}, {"probability": {"variance": 0, "average": 0.999829, "min": 0.99921}, "location": {"width": 180, "top": 827, "height": 28, "left": 128}, "words": "泌尿系统:排尿障碍"}, {"probability": {"variance": 1e-06, "average": 0.997895, "min": 0.996489}, "location": {"width": 98, "top": 857, "height": 25, "left": 90}, "words": "上市后经验"}, {"probability": {"variance": 0, "average": 0.741691, "min": 0.741691}, "location": {"width": 48, "top": 855, "height": 43, "left": 988}, "words": "5"}, {"probability": {"variance": 8e-06, "average": 0.998811, "min": 0.986369}, "location": {"width": 846, "top": 888, "height": 56, "left": 125}, "words": "酒石酸布托啡诺注射液和鼻喷剂上市后的不良反应发生情况与布托啡诺上市前各种途经给药后的不"}, {"probability": {"variance": 3.3e-05, "average": 0.997882, "min": 0.967754}, "location": {"width": 894, "top": 918, "height": 59, "left": 86}, "words": "良反应发生情况相似。与布托啡诺注射液和鼻喷剂有关的、上边未列出的不良反应,由于其严重性、报告"}, {"probability": {"variance": 9.4e-05, "average": 0.995576, "min": 0.956202}, "location": {"width": 884, "top": 950, "height": 58, "left": 86}, "words": "的频率及与布托啡诺可能存在的关系,因此列在下边。因为这些不良反应来自于未知大小人群的自发报告"}, {"probability": {"variance": 0.003781, "average": 0.988693, "min": 0.577487}, "location": {"width": 890, "top": 982, "height": 57, "left": 82}, "words": "因此无法评价发生率。这些不良反应包括呼吸暂停、惊厥、妄想、药物依赖、短暂性说话困难和/或强制"}, {"probability": {"variance": 1.7e-05, "average": 0.99774, "min": 0.977983}, "location": {"width": 671, "top": 1016, "height": 46, "left": 82}, "words": "性行为的药物过度反应,过量用药和眩晕。曾有布托啡诺过量服用致命的报道"}, {"probability": {"variance": 1e-06, "average": 0.999093, "min": 0.997995}, "location": {"width": 109, "top": 1056, "height": 25, "left": 88}, "words": "【禁忌】"}, {"probability": {"variance": 0.000122, "average": 0.993396, "min": 0.961682}, "location": {"width": 343, "top": 1087, "height": 35, "left": 118}, "words": "1.对本品或本品中其它成份过敏者禁用"}, {"probability": {"variance": 0.000212, "average": 0.994332, "min": 0.927924}, "location": {"width": 482, "top": 1119, "height": 39, "left": 117}, "words": "2.因阿片的拮抗特征,本品不宜用于依赖那可汀的患者"}, {"probability": {"variance": 0.000676, "average": 0.991477, "min": 0.901507}, "location": {"width": 237, "top": 1151, "height": 32, "left": 117}, "words": "3.年龄小于18岁患者禁用"}, {"probability": {"variance": 0, "average": 0.999549, "min": 0.999218}, "location": {"width": 103, "top": 1185, "height": 23, "left": 89}, "words": "【注意事项】"}, {"probability": {"variance": 0.004113, "average": 0.935347, "min": 0.871217}, "location": {"width": 41, "top": 1211, "height": 22, "left": 79}, "words": "警告"}, {"probability": {"variance": 0.000277, "average": 0.9914, "min": 0.950858}, "location": {"width": 142, "top": 1244, "height": 24, "left": 76}, "words": "麻醉药依赖患者"}, {"probability": {"variance": 0.000421, "average": 0.993646, "min": 0.866357}, "location": {"width": 855, "top": 1274, "height": 47, "left": 117}, "words": "由于本品的阿片类拮抗剂特性,因此不建议麻醉药依赖患者使用布托啡诺。这些患者在开始使用布托"}, {"probability": {"variance": 0.000287, "average": 0.995669, "min": 0.884706}, "location": {"width": 896, "top": 1305, "height": 48, "left": 75}, "words": "啡诺进行治疗前应该停用阿片类药物足够长的时间。在长期使用阿片类镇痛药的患者中,布托啡诺已经引"}, {"probability": {"variance": 0.000221, "average": 0.993679, "min": 0.938951}, "location": {"width": 688, "top": 1337, "height": 43, "left": 75}, "words": "起了一些戒断症状,例如焦虑、激动、情绪变化、幻觉、烦躁不安、虚弱和腹泻"}, {"probability": {"variance": 1.8e-05, "average": 0.997726, "min": 0.977466}, "location": {"width": 855, "top": 1370, "height": 47, "left": 115}, "words": "由于很难在近期接受多剂量镇静止痛药的患者中评价阿片类药物的耐受性,因此对这些患者应该谨慎"}, {"probability": {"variance": 0.005555, "average": 0.964523, "min": 0.797974}, "location": {"width": 120, "top": 1403, "height": 24, "left": 74}, "words": "使用布托啡诺"}, {"probability": {"variance": 7.7e-05, "average": 0.991235, "min": 0.979137}, "location": {"width": 60, "top": 1436, "height": 24, "left": 93}, "words": "般情况"}, {"probability": {"variance": 1.4e-05, "average": 0.998279, "min": 0.978997}, "location": {"width": 846, "top": 1467, "height": 45, "left": 111}, "words": "使用布托啡诺鼻喷剂初始一小时内罕有低血压晕厥的报道,但仍建议患者避免从事有潜在风险的活"}, {"probability": {"variance": 5e-06, "average": 0.998932, "min": 0.989514}, "location": {"width": 415, "top": 1499, "height": 34, "left": 72}, "words": "动,特别是对阿片类镇痛药有相似反应史的患者"}, {"probability": {"variance": 2.1e-05, "average": 0.996953, "min": 0.984803}, "location": {"width": 200, "top": 1533, "height": 28, "left": 72}, "words": "颅脑损伤与颅内压升高"}], "language": 3}